SERA · XBRL financial data

Sera Prognostics financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (SERA's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue	—	year only	0	24	29	24*	38	17	16	10*	14	30
Revenue from contracts with customers	42	41*	0	24	29	24*	38	17	16	10*	14	30
Cost of revenue	—	year only	17	20	13	32*	40	41	41	42*	42	50
Research and development	3,539	3,895*	3,683	4,406	3,502	3,139*	3,334	3,337	3,284	3,216*	3,030	3,493
General and administrative	3,288	3,666*	4,170	3,752	4,195	4,012*	4,444	4,138	4,079	4,041*	4,290	4,248
Total operating expenses	8,226	8,889*	9,097	9,277	8,891	9,447*	9,288	9,337	8,996	8,964*	9,374	10,034
Operating income (loss)	(8,184)	(8,848)*	(9,097)	(9,253)	(8,862)	(9,423)*	(9,250)	(9,320)	(8,980)	(8,954)*	(9,360)	(10,004)
Interest expense	14	11*	9	8	5	6*	4	2	2	1*	2	2
Income tax expense (benefit)	—	year only	—	—	—	year only	—	—	—	year only	—	—
Net income (loss)	(7,210)	(7,925)*	(8,097)	(8,303)	(7,919)	(8,579)*	(8,187)	(8,046)	(7,814)	(7,881)*	(8,399)	(9,139)
Earnings per share, basic USD per share	(0.23)	(0.25)*	(0.25)	(0.25)	(0.24)	(0.25)*	(0.20)	(0.16)	(0.16)	(0.16)*	(0.17)	(0.18)
Earnings per share, diluted USD per share	(0.23)	(0.25)*	(0.25)	(0.25)	(0.24)	(0.25)*	(0.20)	(0.16)	(0.16)	(0.16)*	(0.17)	(0.18)
Weighted average shares, basic thousands of shares	31,286	31,414*	32,220	32,933	33,523	33,939*	41,968	49,066	49,525	49,980*	50,259	50,477
Weighted average shares, diluted thousands of shares	31,286	31,414*	32,220	32,933	33,523	33,939*	41,968	49,066	49,525	49,980*	50,259	50,477

Balance sheet

CSV

Fiscal quarters (SERA's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	9,655	3,880	4,239	4,664	2,684	4,043	5,230	5,016	4,081	3,944	4,175	4,398
Marketable securities	36,461	45,199	48,734	46,276	47,068	42,193	40,967	35,144	39,223	35,257	43,226	42,047
Marketable securities, non-current	38,922	30,841	32,386	30,006	24,591	21,973	68,004	68,351	59,080	56,579	39,365	33,813
Accounts receivable	155	160	117	101	79	34	25	17	14	12	11	10
Prepaid and other current assets	1,275	795	756	502	1,276	1,311	1,061	693	1,173	1,557	2,314	1,679
Total current assets	47,546	61,344	53,846	51,543	51,107	47,600	47,283	40,870	44,491	40,770	49,726	48,134
Right-of-use asset	1,316	1,180	1,043	902	759	613	464	313	2,460	2,402	2,353	2,306
Total assets	90,057	95,441	89,886	84,861	79,001	72,575	118,184	111,828	108,125	101,933	93,544	86,737
Accounts payable	1,177	1,046	1,026	952	1,378	1,969	1,207	1,063	1,037	862	767	1,190
Total current liabilities	13,545	24,443	24,568	24,757	24,182	24,770	23,401	23,602	23,500	24,188	23,419	24,356
Lease liability, non-current	792	644	487	328	165	0	0	0	2,443	2,337	2,505	3,001
Total liabilities	14,646	25,283	25,136	25,108	24,350	24,772	23,401	23,602	25,943	26,525	25,924	27,357
Accumulated deficit	(238,971)	(246,896)	(254,993)	(263,296)	(271,215)	(279,794)	(287,981)	(296,027)	(303,841)	(311,722)	(320,121)	(329,260)
Total stockholders' equity	75,411	70,158	64,750	59,753	54,651	47,803	94,783	88,226	82,182	75,408	67,620	59,380
Total liabilities and equity	90,057	95,441	89,886	84,861	79,001	72,575	118,184	111,828	108,125	101,933	93,544	86,737

Cash flows

CSV

Fiscal quarters (SERA's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(7,210)	(7,925)*	(8,097)	(8,303)	(7,919)	(8,579)*	(8,187)	(8,046)	(7,814)	(7,881)*	(8,399)	(9,139)
Stock-based compensation	1,182*	1,347*	1,693	2,023*	1,680*	1,617*	1,493	1,344*	1,254*	1,019*	835	823*
Depreciation and amortization	200	212*	213	200	200	211*	216	237*	243*	244*	193	191*
Net cash from operating activities	(7,594)*	(6,765)*	4,994	(5,928)*	(6,995)*	(6,260)*	(7,553)	(5,473)*	(6,477)*	(6,120)*	(8,774)	(6,311)*
Purchases of property and equipment	26*	16*	15	7*	26*	8*	3	281*	112*	330*	8	16*
Net cash from investing activities	(15,164)*	374*	(5,689)	5,149*	4,898*	7,385*	(44,802)	5,241*	5,169*	5,890*	8,985	6,394*
Proceeds from issuing common stock	—	—	0	0*	0*	—	53,610	0*	0*	0*	0	0*
Net cash from financing activities	128*	616*	1,054	1,204*	117*	234*	53,542	18*	373*	93*	20	140*

Compare with peers

SIC 8071 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8071 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Sera Prognostics	4,398	30	(6,311)*	not reported	7.4 quarters	Q2 FY26 10-QJun 30, 2026
Freenome	437	not reported	(130)*	not reported	3.4 quarters	Q2 FY26 10-QJun 30, 2026
Exagen	24,588	19,941	3,988*	24.2M	—	Q2 FY26 10-QJun 30, 2026
Fulgent Genetics	26,305	85,389	(23,758)*	27.5M	10.8 quarters	Q2 FY26 10-QJun 30, 2026
Biodesix	29,996	26,861	(1,562)*	10.6M	19.2 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.